At Aro, we’re developing a patented platform technology called Centyrins that are uniquely positioned to achieve precise targeting of diverse therapeutic payloads to specific cells of interest. Centyrins are small protein domains based on the fibronectin domains of human Tenascin C that combine the
Get weekly curated job picks, salary trends, and career insights delivered to your inbox.